Tianyao Pharmaceutical (600488.SH): Pediatric Compound Amino Acid Injection (18AA-I) has obtained the drug registration certificate from the Ministry of Health of Myanmar.

Zhitong Finance APP News, Jinyao Pharmaceutical (600488.SH) has announced that its subsidiary Jinyao Heping (Tianjin) Pharmaceutical Co., Ltd. (hereinafter referred to as "Jinyao Heping") has received the drug registration certificate from the Ministry of Health of Myanmar for its pediatric compound amino acid injection (18AA-I) (which marks the approval for production and sale of this product in the Myanmar market). This product has successfully obtained qualifications for overseas listing, laying a solid foundation for the company's formulation sector to explore overseas markets and creating new business growth opportunities, which will further promote the steady implementation of the international development strategy.